Serial Number
85594863
Owner
Tissue Regenix LimitedAttorney
Robert L. McRaeFiling Date
Apr 11, 2012
TRX Trademark
Serial Number: 85594863 • Registration: 4975748
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 40 - Treatment & Processing
Treatment of materials
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Correspondence Address
Robert L. McRae Gunn, Lee & Cave P.C.
8023 Vantage Dr., Suite 1500
San Antonio, TX 78230
United States
Trademark Details
Filing Date
April 11, 2012
Registration Date
June 14, 2016
Published for Opposition
March 29, 2016
Goods & Services
[ Treatment of living cells and tissue, namely, removing immunogenic materials; all of aforesaid in the field of replacement tissues for humans and animals and replacement body parts for humans and animals; and none relating to neurological diseases and disorders, neurodegenerative diseases and disorders, infectious diseases and malaria ]
[ Living tissues for surgical implant; ] guided tissue regeneration materials comprised of biological decellularised material; implants comprising biological decellularised tissue for guided tissue regeneration; [ arteriovenous grafts, surgical patches for vascular reconstruction, replacement heart valves, ] small diameter grafts, [ replacement cartilage tissues, all made of living tissue; materials for dressings, namely, gauze swabs, bandages, self-adhesive bandages; ] all of aforesaid in the field of replacement tissues for humans [ and animals and replacement body parts for humans and animals] ; and none relating to neurological diseases and disorders, neurodegenerative diseases and disorders, infectious diseases and malaria
[ Implantable textile material to encourage the growth of tissue; ] replacement tissue, namely, artificial tissue being non-living surgical implants originally derived from humans [ and animals, ] intended for subsequent implantation comprising [ bone, ] skin, skin grafts, [ ureters, bladders, tendons, cartilage, ligaments, blood vessels, nerves, ] dermal replacements, tissue for use in treating chronic and acute wounds, tissue for use in treating burns, [ and soft tissue used in the heart and pericardium; replacement prosthetic tissue for replacing animal tissue; ] replacement prosthetic tissue for replacing human tissue; [ implantable medical scaffolds comprising artificial materials for assisting regeneration of living tissue for living tissue; prosthetic arteriovenous grafts, prosthetic replacement heart valves, ] prosthetic small diameter grafts; [ suture materials; ] all of aforesaid in the field of replacement tissues for humans [ and animals and replacement body parts for humans and animals ] ; and none relating to neurological diseases and disorders, neurodegenerative diseases and disorders, infectious diseases and malaria
[ Research and design services in the field of replacement tissues for humans and animals, regenerative medical devices; laboratory services, namely, research pertaining to material treatment for the production of living cells, production and decellularisation of tissue, treatment of replacement tissues for use in the human body and in animals; all of aforesaid in the field of replacement tissues for humans and animals and replacement body parts for humans and animals; and none relating to neurological diseases and disorders, neurodegenerative diseases and disorders, infectious diseases and malaria ]
